2nd National Conference of Clinical Advances in Myeloma
America Square Conference Centre *London, UK Visit the Venue to read more
The clinical advances in multiple myeloma have made great strides over the past few years, with the advent of novel therapeutic drugs dramatically improving both remission and survival rates in myeloma patients. There is still however a great deal of research currently underway investigating both current and emerging treatments in order to develop the most effective clinical practices in the treatment of multiple myeloma.
Clinical Advances in Myeloma 2018 is a one day CPD certified conference, in association with The British Journal of Hospital Medicine, that aims to provide healthcare professionals with the most up-to-date clinical knowledge regarding the diagnosis, treatment and management of myeloma. This conference also provides the unique opportunity for clinicians to discuss the current controversial topics in myeloma in interactive case studies and panel discussions led by experts in the field.
Topics due to be discussed:
Changes in Imaging Practice
Personalised Cancer Treatment
Current and Emerging Treatments
Improving Stem-Cell Therapy Outcomes
Surgical Interventions for Mylemoa Bone Disease
Managing Smouldering Myeloma
Patient Case Studies
Patient Centred Models of Care
Who should attend?
Specialists in transplantation
Clinical nurse specialists
All trainees in these disciplines
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Clinical Advances in Myeloma 2018 will feature an exhibition (with limited spaces available) of relevant products to the healthcare professionals attending.
For more information about exhibition & sponsorship, please contact Sam Yekta on +44 (0)20 7501 6679 or email@example.com
Contact No.: +44 (0)20 7501 6762